Neurology

Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MS




Investigators conducted a meta-analyses to determine whether injectable IFN-β and glatiramer acetate both decrease the annualized relapse rate and slow disease progression in patients with RRMS.

Source link




Related posts

clinical neurology; +286 new citations

Newsemia

Science Blog: CT scans may increase the risk of brain cancer

Newsemia

Novel Narcolepsy Treatment Gets Orphan Drug Designation

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy